Principal Financial Group Inc Vertex Pharmaceuticals Inc Transaction History

Principal Financial Group Inc

  • $172 Billion
  • Q3 2024

A detailed history of Principal Financial Group Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Principal Financial Group Inc holds 410,359 shares of VRTX stock, worth $185 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
410,359
Previous 388,710 5.57%
Holding current value
$185 Million
Previous $182 Million 4.75%
% of portfolio
0.11%
Previous 0.11%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024
BUY
$460.0 - $505.78 $9.96 Million - $10.9 Million
21,649 Added 5.57%
410,359 $191 Million
Q2 2024

Jul 29, 2024
BUY
$392.81 - $485.53 $10 Million - $12.4 Million
25,573 Added 7.04%
388,710 $182 Million
Q1 2024

Apr 29, 2024
SELL
$407.69 - $446.08 $2.28 Million - $2.49 Million
-5,591 Reduced 1.52%
363,137 $152 Million
Q4 2023

Feb 07, 2024
BUY
$343.0 - $410.68 $13.7 Million - $16.4 Million
40,005 Added 12.17%
368,728 $150 Million
Q3 2023

Nov 02, 2023
SELL
$338.18 - $362.46 $750,759 - $804,661
-2,220 Reduced 0.67%
328,723 $114 Million
Q2 2023

Aug 07, 2023
SELL
$314.42 - $351.91 $831,326 - $930,450
-2,644 Reduced 0.79%
330,943 $116 Million
Q1 2023

May 09, 2023
BUY
$283.23 - $323.1 $697,595 - $795,795
2,463 Added 0.74%
333,587 $105 Million
Q4 2022

Feb 09, 2023
SELL
$285.76 - $321.48 $7.15 Million - $8.05 Million
-25,034 Reduced 7.03%
331,124 $95.6 Million
Q3 2022

Nov 09, 2022
BUY
$273.83 - $305.53 $10.9 Million - $12.1 Million
39,731 Added 12.56%
356,158 $103 Million
Q2 2022

Aug 10, 2022
BUY
$234.96 - $292.55 $3.66 Million - $4.56 Million
15,590 Added 5.18%
316,427 $89.2 Million
Q1 2022

May 09, 2022
SELL
$221.42 - $260.97 $1.21 Million - $1.43 Million
-5,475 Reduced 1.79%
300,837 $78.5 Million
Q4 2021

Feb 09, 2022
SELL
$177.01 - $223.45 $2.43 Million - $3.07 Million
-13,734 Reduced 4.29%
306,312 $67.3 Million
Q3 2021

Nov 09, 2021
BUY
$181.39 - $202.99 $844,914 - $945,527
4,658 Added 1.48%
320,046 $58.1 Million
Q2 2021

Aug 10, 2021
SELL
$187.49 - $221.1 $2.18 Million - $2.57 Million
-11,611 Reduced 3.55%
315,388 $63.6 Million
Q1 2021

May 10, 2021
SELL
$207.02 - $241.31 $4.48 Million - $5.22 Million
-21,630 Reduced 6.2%
326,999 $70.3 Million
Q4 2020

Feb 08, 2021
SELL
$207.01 - $276.09 $3.88 Million - $5.17 Million
-18,731 Reduced 5.1%
348,629 $82.4 Million
Q3 2020

Nov 06, 2020
SELL
$255.65 - $303.1 $6.22 Million - $7.37 Million
-24,321 Reduced 6.21%
367,360 $100 Million
Q2 2020

Aug 05, 2020
BUY
$225.48 - $295.8 $5.19 Million - $6.81 Million
23,036 Added 6.25%
391,681 $114 Million
Q1 2020

May 12, 2020
BUY
$199.77 - $247.81 $134,045 - $166,280
671 Added 0.18%
368,645 $87.7 Million
Q4 2019

Feb 05, 2020
SELL
$166.71 - $223.91 $1.54 Million - $2.07 Million
-9,263 Reduced 2.46%
367,974 $80.6 Million
Q3 2019

Nov 13, 2019
SELL
$166.23 - $187.09 $332,293 - $373,992
-1,999 Reduced 0.53%
377,237 $63.9 Million
Q2 2019

Aug 12, 2019
BUY
$164.61 - $190.37 $267,491 - $309,351
1,625 Added 0.43%
379,236 $69.5 Million
Q1 2019

May 10, 2019
SELL
$163.73 - $194.7 $210,720 - $250,578
-1,287 Reduced 0.34%
377,611 $69.5 Million
Q4 2018

Feb 14, 2019
SELL
$151.91 - $192.21 $840,062 - $1.06 Million
-5,530 Reduced 1.44%
378,898 $62.8 Million
Q3 2018

Nov 14, 2018
BUY
$167.73 - $192.74 $1.33 Million - $1.53 Million
7,957 Added 2.11%
384,428 $74.1 Million
Q2 2018

Aug 13, 2018
SELL
$145.72 - $169.96 $67,176 - $78,351
-461 Reduced 0.12%
376,471 $0
Q1 2018

May 14, 2018
SELL
$151.6 - $177.13 $48,815 - $57,035
-322 Reduced 0.09%
376,932 $61.4 Million
Q4 2017

Feb 13, 2018
BUY
$137.28 - $155.55 $748,176 - $847,747
5,450 Added 1.47%
377,254 $56.5 Million
Q3 2017

Nov 02, 2017
BUY
$148.13 - $162.24 $55.1 Million - $60.3 Million
371,804
371,804 $56.5 Million

Others Institutions Holding VRTX

# of Institutions
1,723
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email